Alejandro R Jadad

Alejandro R Jadad


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
NSNelson Shen
Nelson Shen
MLMichael-Jane Levitan
Michael-Jane Levitan
AJAndrew Cameron Johnson
Andrew Cameron Johnson
Jacqueline BenderJacqueline Bender
Jacqueline Bender
MHMichelle Hamilton-Page
Michelle Hamilton-Page
DWDavid Wiljer
David Wiljer
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

25 October 2024 in European Spine Journal
Verified
Journal Article
Open access
PDF file
CHCesar A. Hincapié
Cesar A. Hincapié
DKDaniela Kroismayr
Daniela Kroismayr
LHLéonie Hofstetter
Léonie Hofstetter
AKAstrid Kurmann
Astrid Kurmann
CCCarol Cancelliere
Carol Cancelliere
JCJ. David Cassidy
J. David Cassidy
Background: Lumbar disc herniation (LDH) with radiculopathy is associated with greater pain, disability, healthcare use, and costs compared with nonspecific low back pain. Reliable information about its incidence and risk factors were lacking. Questions: (1) What is the incidence of lumbar disc herniation (LDH) with radiculopathy in adults? (2) What are the risk factors for LDH with radiculopathy in adults? Methods: Systematic review. We searched five electronic databases from 1970 to September 2023. Eligible cohort and case–control studies were identified and independently assessed for risk of bias. A qualitative best evidence synthesis of low and moderate risk of bias studies was conducted. Results: We critically reviewed 87 studies and synthesised data from 59 (68%) studies; 12 were of low and 47 of moderate risk of bias. The lower and upper bound limits of the 95% CIs of annual incidence estimates ranged from 0.3 to 2.7 per 1000 persons for surgical case definitions, from 0.04 to 1.5 per 1,000 persons for hospital-based case definitions, and from 0.1 to 298.3 per 1,000 persons for clinical case definitions. Factors associated with the development of LDH with radiculopathy included middle-age (30–50 years), smoking, higher BMI, presence of cardiovascular risk factors (in women), and greater cumulative occupational lumbar load by forward bending postures and manual materials handling, with effect sizes ranging from ranging from 1.1 (1.0–1.3) to 3.7 (2.3–6.0). Conclusions: Incidence of LDH varies in different populations and according to case definition. Risk factors include individual, behavioural, and work-related variables. Our findings support the need to develop standardised case definitions that validly classify the clinical spectrum of LDH and for future low risk of bias studies examining causal relationships for LDH with radiculopathy in adults.

1 September 2021 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
MZMehreen Zaman
Mehreen Zaman
SESara Espinal-Arango
Sara Espinal-Arango
AMAshita Mohapatra
Ashita Mohapatra
AJAlejandro R Jadad
Alejandro R Jadad
The medicalisation of life under the influence of health-care systems, focused on curing diseases, has made dying well challenging. This systematic review identifies common themes from published systematic reviews about the conditions for a good death as a means to guide decisions around this universal event. MEDLINE, Embase, APA PsycInfo, and AMED were searched for citations with "good death" or "dying well" in their titles on Sept 23, 2020, and complemented with backward reference and forward citation screening with Google Scholar. Articles published in peer-reviewed journals in any language were included. Articles that focused on the identification of conditions for a good death and described how primary studies were sought and selected were also included. Data on general characteristics, quality, and themes were extracted independently. 13 of 275 potentially eligible reviews were included. Common themes were dying at the preferred place, relief from pain and psychological distress, emotional support from loved ones, autonomous treatment decision making, avoidance of futile life-prolonging interventions and of being a burden to others, right to assisted suicide or euthanasia, effective communication with professionals, and performance of rituals. No reviews specified the meaning or timing of death, connected themes, or prioritised them. Vague jargon was often used to describe complex concepts. Most conditions for a good death could be offered to most dying people, without costly medical infrastructure or specialised knowledge. Efforts to describe these conditions clearly, to identify whether there are exceptions or missing items, and whether they apply in non-dominant settings (ie, outstide institutional, affluent, anglophone, and Christian settings) are needed.

28 December 2011 in JAMA
Verified
Journal Article
Open access
PDF file
AJAlejandro R Jadad
Alejandro R Jadad
MTMatthew J. To
Matthew J. To
MEMohamed Emara
Mohamed Emara
JJJennifer Jones
Jennifer Jones
To the Editor: Before approval of a new drug, the US Food and Drug Administration (FDA) requires phase 3 clinical trials demonstrating efficacy. Usually trials are conducted in homogeneous populations and rarely include individuals with multiple chronic conditions. In the United States, more than 50% of people with chronic conditions have 2 or more diseases.1 Twenty-eight percent of the population lives with multiple chronic conditions, including 2 of 3 older individuals.2 Multiple chronic conditions account for 66% of the country's overall health expenditures2 and more than 95% of Medicare expenditures.3

31 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMatthew J To
Matthew J To
JJJennifer Jones
Jennifer Jones
MEMohamed Emara
Mohamed Emara
AJAlejandro R Jadad
Alejandro R Jadad
Inadequate reporting undermines findings of randomized controlled trials (RCTs). This study assessed and compared articles published in high-impact general medical and specialized journals. Reports of RCTs published in high-impact general and specialized medical journals were identified through a search of MEDLINE from January to March of 1995, 2000, 2005, and 2010. Articles that provided original data on adult patients diagnosed with chronic conditions were included in the study. Data on trial characteristics, reporting of allocation concealment, quality score, and the presence of a trial flow diagram were extracted independently by two reviewers, and discrepancies were resolved by consensus or independent adjudication. Descriptive statistics were used for quantitative variables. Comparisons between general medical and specialized journals, and trends over time were performed using Chi-square tests. Reports of 284 trials were analyzed. There was a significantly higher proportion of RCTs published with adequate reporting of allocation concealment (p = 0.003), presentation of a trial flow diagram (p<0.0001) and high quality scores (p = 0.038) over time. Trials published in general medical journals had higher quality scores than those in specialized journals (p = 0.001), reported adequate allocation concealment more often (p = 0.013), and presented a trial flow diagram more often (p<0.001). We found significant improvements in reporting quality of RCTs published in high-impact factor journals over the last fifteen years. These improvements are likely attributed to concerted international efforts to improve reporting quality such as CONSORT. There is still much room for improvement, especially among specialized journals.

20 April 2006 in BMJ
Verified
Journal Article
Closed access
PDF file
AJAlejandro R Jadad
Alejandro R Jadad
MEMurray W Enkin
Murray W Enkin
SGSholom Glouberman
Sholom Glouberman
PGPhilip Groff
Philip Groff
ASAnita Stern
Anita Stern
Footnotes Competing interests None declared. Research p 939